The Anti-Thyroid Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Anti-Thyroid Drugs Market?
The market size of anti-thyroid drugs has been experiencing a consistent increase over the years. It is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 2.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Anti-Thyroid Drugs Industry?
The global market for anti-thyroid drugs is anticipated to expand in the future, reaching an estimated value of $2.78 billion by 2029. This equates to a compound annual growth rate (CAGR) of 2.7%.
Download Your Free Sample of the 2025 Anti-Thyroid Drugs Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Anti-Thyroid Drugs Market?
The key drivers in the anti-thyroid drugs market are:
• Rise in patient awareness and educational initiatives
• Increase in healthcare expenditure globally
• Shifts in patient demographics
• Variation in global economic conditions
Global Market Segmentation: Identifying Major Anti-Thyroid Drugs Industry Segments
The anti-thyroid drugs market covered in this report is segmented –
1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral, Intravenous, Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels
Pre-order the 2025 Anti-Thyroid Drugs Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Anti-Thyroid Drugs Market?
The key trends in the anti-thyroid drugs market are:
• The trend of exploring alternatives to thyroid surgery and radioactive iodine represents an important shift in the anti-thyroid drugs market.
• The concept of patient-centric care is becoming more prevalent in the market for anti-thyroid drugs.
• The adoption of telemedicine and remote monitoring is an emerging trend in the anti-thyroid drugs market.
• The role of patient demographics, global economic conditions, and healthcare expenditure in shaping the future of the market is increasingly significant.
Who Are the Top Competitors & Leading Players in the Anti-Thyroid Drugs Market?
Major companies in the anti-thyroid drugs market are:
• Mylan N.V.
• Abbott Laboratories
• GlaxoSmithKline plc
• Merck & Co.
• AbbVie Inc.
• Pfizer Inc.
• Allergan plc
• RLC LABS Inc.
• Amgen Inc.
• Lannett Company Inc.
• Sanofi S.A.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Aspen Pharmacare Holdings Limited
• Astellas Pharma Inc.
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Daiichi Sankyo Company Limited
• Roche Holding AG
• Bayer AG
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Cipla Inc.
• Lupin Limited
• Cadila Healthcare Limited
• Torrent Pharmaceuticals Ltd.
• Alkem Laboratories Ltd.
• Akorn Inc.
Regional Dominance: Which Area Leads the Global Anti-Thyroid Drugs Market?
North America was the largest region in the anti-thyroid drugs market in 2023
